Close
Home - Press releases - Ethypharm ready to bring to patients world-leading digital therapies for depression and addiction

Do you have
any question?

Contact us
06/04/2021

Ethypharm ready to bring to patients world-leading digital therapies for depression and addiction

Saint-Cloud, France – April 6th, 2021 – Ethypharm announces today that it has acquired exclusive rights for two CE-marked digital therapies, deprexis® and vorvida®, developed by GAIA AG (GAIA), a global leader in digital therapeutics. With these innovative clinically-proven digital therapies, Ethypharm strengthens its product offering to support patients and healthcare providers in its core area of the Central Nervous System (CNS) where there are significant unmet needs.

Press release

Media enquiries

Please provide a valid state.
Please provide a valid state.
Please provide a valid state.
(+)
Please provide a valid state.
Please provide a valid state.
Please provide a valid state.
*All fields must be filled in

Thank you for your message!
We will examine it with utmost attention and get back to you shortly.